Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | ANPEP | P15144 | 5/20 | 0.40 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.40 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 2/20 | 0.38 |
| ▸ | METAP1 | P53582 | 2/20 | 0.38 |
| ▸ | PPID | Q08752 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL839402 | 1.00 | SLC7A5 (0.54) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| SCHEMBL196637 | 1.00 | SLC7A5 (0.54) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL10887590 | 0.98 | SLC7A5 (0.52) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL818970 | 0.98 | SLC7A5 (0.52) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL133091 | 0.98 | SLC7A5 (0.52) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL6846663 | 0.96 | SLC7A5 (0.50) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| SCHEMBL10866196 | 0.94 | SLC7A5 (0.48) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Phosphoric Acid SCHEMBL28734810 | 0.92 | SLC7A5 (0.47) | SLC7A5ALOX15SLC1A3SLC1A2ANPEP | |
| Sulfuric Acid SCHEMBL28734782 | 0.92 | SLC7A5 (0.47) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| SCHEMBL28856635 | 0.90 | SLC7A5 (0.45) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122030612-A | Shear-resistant slow-release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4673426-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | Locus Solutions IPCO, LLC (US) | 2026-01-07 | — | — | EP | claimed |
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | SOOCHOW UNIVERSITY (CN) | 2025-02-27 | — | — | US | claimed |
| EP-3781573-B1 | NOVEL ANTIMALARIAL COMPOUNDS, PROCESS FOR PREPARATION AND THEIR USE FOR DRUG RESISTANT MALARIA | COUNCIL SCIENT IND RES (IN) | 2024-09-18 | — | — | EP | claimed |
| US-20240301322-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO LLC (US) | 2024-09-12 | — | — | US | claimed |
| WO-2024182125-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-09-06 | — | — | WO | claimed |
| WO-2024175614-A1 | STABLE LIQUID FORMULATIONS COMPRISING (6S)-5-METHYLTETRAHYDROFOLIC ACID OR SALTS THEREOF | MERCK PATENT GMBH (DE) | 2024-08-29 | — | — | WO | claimed |
| WO-2024065907-A1 | PENTACYCLIC TRITERPENE SAPONIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 苏州大学 | 2024-04-04 | — | — | WO | claimed |
| US-11925644-B2 | Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl ester | MERCK PATENT GMBH (DE) | 2024-03-12 | — | — | US | claimed |
| EP-1161480-B1 | BIODEGRADABLE AND THERMOSENSITIVE POLYPHOSPHAZENES AND THEIR PREPARATION METHOD | KOREA INST SCI & TECH (KR) | 2004-12-22 | — | — | EP | claimed |
| EP-1161480-A1 | BIODEGRADABLE AND THERMOSENSITIVE POLYPHOSPHAZENES AND THEIR PREPARATION METHOD | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-12-12 | — | — | EP | claimed |
| US-6319984-B1 | TEMPERATURE-SENSITIVITY AND BIODEGRADABILITY CAN BE CONTROLLED AS DESIRED BY SUBSTITUTING POLYDICHLOROPHOSPHAZENE WITH METHOXY HEPTA(ETHYLENE GLYCOL), DEPSIPEPTIDES AND AMINO ACID ESTERS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-11-20 | — | — | US | claimed |
| WO-2001036516-A1 | BIODEGRADABLE AND THERMOSENSITIVE POLYPHOSPHAZENES AND THEIR PREPARATION METHOD | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-05-25 | — | — | WO | claimed |
| EP-0736169-A4 | METHOD FOR OBTAINING A CELL POPULATION ENRICHED IN STEM CELLS AND COMPOSITIONS DERIVED THEREFROM | SYSTEMIX INC (US) | 1998-06-10 | — | — | EP | claimed |
| EP-0799239-A2 | DIASTEREOMERICALLY PURE 3-OXO AND 3-THIOXO-4-AZA-ANDROSTAN DERIVATIVES AND THE USE THEREOF AS ANTIANDROGENS | POLI INDUSTRIA CHIMICA S.p.A. (IT) | 1997-10-08 | — | — | EP | claimed |
| EP-0736169-A1 | METHOD FOR OBTAINING A CELL POPULATION ENRICHED IN STEM CELLS AND COMPOSITIONS DERIVED THEREFROM | SYSTEMIX, INC. (US) | 1996-10-09 | — | — | EP | claimed |
| WO-1996020210-A2 | DIASTEREOMERICALLY PURE 3-OXO AND 3-THIOXO-4-AZA-ANDROSTAN DERIVATIVES AND THE USE THEREOF AS ANTIANDROGENS | POLI INDUSTRIA CHIMICA S.P.A. (IT) | 1996-07-04 | — | — | WO | claimed |
| WO-1995008105-A1 | METHOD FOR OBTAINING A CELL POPULATION ENRICHED IN STEM CELLS AND COMPOSITIONS DERIVED THEREFROM | SYSTEMIX, INC. (US) | 1995-03-23 | — | — | WO | claimed |
| US-4940662-A | Low-molecular weight peptide mixture and method of producing same | TERUMO KABUSHIKI KAISHA (JP) | 1990-07-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | CASP4, CASP3, CASP14 | SLC7A5 4000/4885ALOX15 417/4885SLC1A3 3592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.